C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin et al., A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload, Journal of Biological Chemistry, vol.46, issue.11, pp.7811-7820, 2001.
DOI : 10.1074/jbc.M008922200

T. Ganz, E. Nemeth, M. S. Tuttle, J. Powelson, M. B. Vaughn et al., Hepcidin and iron regulation, 10 years later Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Blood. Science, vol.1175, issue.306, pp.4425-4458, 2004.

S. Rivera, L. Liu, E. Nemeth, V. Gabayan, O. E. Sorensen et al., Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia, Blood, vol.105, issue.4, pp.1797-802, 2005.
DOI : 10.1182/blood-2004-08-3375

E. Kemna, P. Pickkers, E. Nemeth, H. Van-der-hoeven, and D. Swinkels, Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS, Blood, vol.106, issue.5, pp.1864-1870, 2005.
DOI : 10.1182/blood-2005-03-1159

D. M. Wrighting, N. C. Andrews, A. Pietrangelo, U. Dierssen, L. Valli et al., Interleukin-6 induces hepcidin expression through STAT3 STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo, Blood. Gastroenterology, vol.108, issue.132, pp.3204-3213, 2006.

V. Falzacappa, M. V. Vujic-spasic, M. Kessler, R. Stolte, J. Hentze et al., STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation, Blood, vol.109, issue.1, pp.353-361, 2007.
DOI : 10.1182/blood-2006-07-033969

G. Weiss and L. T. Goodnough, Anemia of Chronic Disease, New England Journal of Medicine, vol.352, issue.10, pp.1011-1034, 2005.
DOI : 10.1056/NEJMra041809

S. Gardenghi, T. M. Renaud, A. Meloni, C. Casu, B. J. Crielaard et al., Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus, Blood, vol.123, issue.8, pp.1137-1182, 2014.
DOI : 10.1182/blood-2013-08-521625

T. Ganz, Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation, Blood, vol.102, issue.3, 2003.
DOI : 10.1182/blood-2003-03-0672

C. C. Sun, V. Vaja, J. L. Babitt, and H. Y. Lin, Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation, American Journal of Hematology, vol.86, issue.1 Suppl
DOI : 10.1002/ajh.22117

K. S. Cooke, B. Hinkle, H. Salimi-moosavi, I. Foltz, C. King et al., A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates, Blood, vol.122, issue.17, pp.3054-61, 2013.
DOI : 10.1182/blood-2013-06-505792

N. Fatih, E. Camberlein, M. L. Island, A. Corlu, E. Abgueguen et al., Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form, Journal of Molecular Medicine, vol.40, issue.54, pp.477-86, 2010.
DOI : 10.1016/S0002-9440(10)63352-4

URL : https://hal.archives-ouvertes.fr/hal-00742152

R. A. Sharma, W. P. Steward, and A. J. Gescher, PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN, Adv Exp Med Biol, vol.595, pp.453-70, 2007.
DOI : 10.1007/978-0-387-46401-5_20

R. A. Sharma, A. J. Gescher, and W. P. Steward, Curcumin: The story so far, European Journal of Cancer, vol.41, issue.13, pp.1955-68, 2005.
DOI : 10.1016/j.ejca.2005.05.009

A. Angeli, F. Laine, A. Lavenu, M. Ropert, K. Lacut et al., Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women, The AAPS Journal, vol.18, issue.2, pp.490-504, 2016.
DOI : 10.1208/s12248-016-9875-4

URL : https://hal.archives-ouvertes.fr/hal-01274215

F. Laine, A. Angeli, M. Ropert, C. Jezequel, E. Bardou-jacquet et al., Variations of hepcidin and iron-status parameters during the menstrual cycle in healthy women, British Journal of Haematology, vol.59, issue.5, pp.980-982, 2016.
DOI : 10.1373/clinchem.2012.194977

URL : https://hal.archives-ouvertes.fr/hal-01255848

A. Rasyid, A. R. Rahman, K. Jaalam, and A. Lelo, Effect of different curcumin dosages on human gall bladder, Asia Pacific Journal of Clinical Nutrition, vol.72, issue.4, pp.314-322, 2002.
DOI : 10.1023/A:1018804927516

J. J. Kroot, A. E. Van-herwaarden, H. Tjalsma, R. T. Jansen, J. C. Hendriks et al., Second round robin for plasma hepcidin methods: First steps toward harmonization, American Journal of Hematology, vol.49, issue.10, pp.977-83, 2012.
DOI : 10.1182/blood-2009-01-201590

URL : http://onlinelibrary.wiley.com/doi/10.1002/ajh.23289/pdf

E. Aigner, T. K. Felder, H. Oberkofler, P. Hahne, S. Auer et al., Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations, The Journal of Nutritional Biochemistry, vol.24, issue.1, pp.112-119, 2013.
DOI : 10.1016/j.jnutbio.2012.02.017

F. Laine, B. Laviolle, M. Ropert, G. Bouguen, J. Morcet et al., Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers, European Journal of Applied Physiology, vol.89, issue.Suppl 5, pp.1391-1398, 2012.
DOI : 10.3945/ajcn.2008.26589

URL : https://hal.archives-ouvertes.fr/hal-00739839

J. J. Kroot, J. C. Hendriks, C. M. Laarakkers, S. M. Klaver, E. H. Kemna et al., (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: Implications for clinical studies, Analytical Biochemistry, vol.389, issue.2, pp.124-133, 2009.
DOI : 10.1016/j.ab.2009.03.039

M. F. Borsari, E. Grandi, R. Saladini, M. Pineda, M. Ramirez-silva et al., Curcuminoids as potential new ironchelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water, Inorg Chim Acta. Spectrochim Acta A Mol Biomol Spectrosc, vol.32827, issue.60, pp.1105-1118, 2002.

D. Chin, P. Huebbe, J. Frank, G. Rimbach, and K. Pallauf, Curcumin may impair iron status when fed to mice for six months, Redox Biology, vol.2, pp.563-572, 2014.
DOI : 10.1016/j.redox.2014.01.018

URL : http://doi.org/10.1016/j.redox.2014.01.018

Y. Jiao, J. T. Wilkinson, X. Di, W. Wang, H. Hatcher et al., Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator, Blood, vol.113, issue.2, pp.462-471, 2009.
DOI : 10.1182/blood-2008-05-155952

URL : http://www.bloodjournal.org/content/bloodjournal/113/2/462.full.pdf

A. L. Cheng, C. H. Hsu, J. K. Lin, M. M. Hsu, Y. F. Ho et al., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, vol.21, pp.2895-900, 2001.

W. Liu, Y. Zhai, X. Heng, F. Y. Che, W. Chen et al., Oral bioavailability of curcumin: problems and advancements, Journal of Drug Targeting, vol.21, issue.8, pp.694-702, 2016.
DOI : 10.1039/c3ra46396f

C. Vecchi, G. Montosi, C. Garuti, E. Corradini, M. Sabelli et al., Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin??in??Mice, Gastroenterology, vol.146, issue.4, pp.1060-1069, 2014.
DOI : 10.1053/j.gastro.2013.12.016

URL : http://doi.org/10.1053/j.gastro.2013.12.016

H. Wang, H. Li, X. Jiang, W. Shi, Z. Shen et al., Hepcidin Is Directly Regulated by Insulin and Plays an Important Role in Iron Overload in Streptozotocin-Induced Diabetic Rats, Diabetes, vol.63, issue.5, pp.1506-1524, 2014.
DOI : 10.2337/db13-1195